IRONWOOD PHARMACEUTICALS INC (IRWD) Stock Analyst Ratings
USA - NASDAQ:IRWD - US46333X1081 - Common Stock
1.87 USD
+0.01 (+0.54%)
1.87 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 50% to IRWD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 0.97. This target is -48.18% below the current price.
IRWD was analyzed by 10 analysts. The buy percentage consensus is at 50. So analysts seem to be rather neutral about IRWD.
In the previous month the buy percentage consensus was at a similar level.
IRWD was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-15 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-04-15 | Jefferies | Downgrade | Buy -> Hold |
| 2025-04-14 | Leerink Partners | Maintains | Market Perform -> Market Perform |
| 2025-01-30 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-01-22 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-09-09 | Leerink Partners | Initiate | Market Perform |
| 2024-08-09 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-08-09 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-05-10 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-03-01 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-02-16 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-01-17 | Craig-Hallum | Initiate | Buy |
| 2023-12-14 | Wells Fargo | Initiate | Overweight |
| 2023-09-28 | JMP Securities | Initiate | Market Outperform |
| 2023-05-23 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2022-08-16 | Wells Fargo | Maintains | Equal-Weight |
| 2022-04-22 | Piper Sandler | Initiate | Overweight |
| 2021-10-12 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-07-16 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-02-22 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-02-19 | Morgan Stanley | Maintains | Equal-Weight |
IRONWOOD PHARMACEUTICALS INC / IRWD FAQ
What is the price target for IRWD stock?
10 analysts have analysed IRWD and the average price target is 0.97 USD. This implies a price decrease of -48.18% is expected in the next year compared to the current price of 1.87.
What is the consensus rating for IRWD stock?
The consensus rating for IRONWOOD PHARMACEUTICALS INC (IRWD) is 50 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
What is the number of analysts for IRWD stock?
The number of analysts covering IRONWOOD PHARMACEUTICALS INC (IRWD) is 10.